In the past number of years, the united kingdom has witnessed a revolution in health-related bodyweight‑reduction solutions — within the introduction of semaglutide (Wegovy®) towards the expanding popularity of tirzepatide (Mounjaro®). Now, A further name is drawing focus in both equally clinical